NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
NASDAQ · MODV · USD
Stock price, earnings
Quote as of Sep 4, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ModivCare Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.68% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ModivCare Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ModivCare Inc. is a healthcare enterprise leveraging technology to deliver an integrated suite of supportive care solutions. Its services cater to both public and private payers, as well as individual patients. The company organizes its operations into four distinct divisions: Non-Emergency Medical Transportation (NEMT): This segment manages crucial logistics, including contact center operations, network credentialing, and claims processing, alongside coordinating non-emergency medical rides. This service is vital for individuals eligible for Medicaid or Medicare whose mobility challenges or financial constraints would otherwise impede their access to essential healthcare and social support. Personal Care: The Personal Care division dispatches non-medical personal care assistants, home health aides, and skilled nurses to provide comprehensive assistance with daily living activities. These services, predominantly for Medicaid beneficiaries, elderly individuals, and disabled adults, encompass personal hygiene (e.g., bathing, grooming, oral care), dressing, medication reminders, meal preparation and feeding, light housekeeping, and transportation, as well as aid with ambulation. Remote Patient Monitoring (RPM): Through its RPM segment, ModivCare offers advanced technological solutions like personal emergency response systems, continuous vital sign monitoring, medication management tools, and data-driven engagement platforms for patients. Matrix Investment: This segment focuses on delivering care directly within patients' homes or at specific on-site locations. This includes a fleet of mobile health clinics designed to provide community-based care, equipped with sophisticated diagnostic capabilities and a variety of treatment options. ModivCare's clientele spans a wide array, including federal, state, and local government bodies, Managed Care Organizations (MCOs), commercial insurance providers, private citizens, and various health systems. Incorporated in 1996, the company was formerly known as The Providence Service Corporation until its rebranding as ModivCare Inc. in January 2021. Its corporate headquarters are situated in Denver, Colorado.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2024 | May 2, 2024 | -$0.09-145.0% vs estimate | $684.45M-1.41% vs estimate |
|---|
| Q4 2023 | Feb 22, 2024 | $1.29+5.74% vs estimate | $702.83M+0.88% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$2.85-$0.15 (-5.0%)
Entero Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.2% below the high.
$5.80$0.00 (0.0%)
Regional Health Properties, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.43% below the high.
$0.11$0.00 (0.0%)
Tricida, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.22% below the high.
$0.12-$0.08 (-40.69%)
Greenbrook TMS Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.77% below the high.
$0.02-$0.01 (-35.59%)
Invitae Corporation’s quoted price sits in the lower half of its reported 52-week range, 99.19% below the high.
$0.02$0.00 (0.0%)
LumiraDx Limited’s quoted price sits in the lower half of its reported 52-week range, 43.26% below the high.
$0.11-$0.06 (-37.43%)
NanoString Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.78% below the high.
